From a "Nine-Year Date" to a "10-Year Pledge": A long-term commitment delivered on the CIIE stage
Over nine years, "perfect attendance" has become a defining mark of how Bayer and the CIIE have grown together. This year, Bayer exhibited for the ninth consecutive time and received the CIIE's "Nine-Time Perfect Attendance" honor, and signed up for the 10th CIIE in advance, moving toward a full 10 years of perfect attendance.
Behind this continuity is a more concrete CIIE "report card". As of the ninth CIIE, Bayer has brought a cumulative total of 98 debut exhibits, helped land 24 "CIIE babies", held and participated in nearly 200 events inside and outside its booth, and reached more than 60 landmark signings.
Over these nine years, the way Bayer takes part in the CIIE has also evolved. When Bayer first exhibited in 2018, the CIIE was mainly a window for global innovation to accelerate its entry into China. Today, from the launch of innovative products, to local innovation partnerships, to clinical data, research capabilities and innovation outcomes from China contributing to broader R&D and innovation, Bayer's collaboration with the Chinese market continues to deepen.
Nine editions of "perfect attendance" mark a long-term commitment, and signing up early for the 10th CIIE begins the next chapter. In 2027, Bayer will also mark its 145th anniversary in China. From a "nine-year date" to a "10-year pledge", continued participation in the CIIE has become a microcosm of Bayer's long-term commitment to China and its participation in China's innovation-driven development.
